The Global Autoimmune Disease Diagnostics Market is classified into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Global Autoimmune Disease Diagnostics Market to Grow at CAGR of 8.4% from 2022-2027
The Autoimmune Disease Diagnostics Market will be USD 8.02 Billion by 2027. Autoimmune disorders are a species of more than 80 chronic diseases, out of which multiple sclerosis, Systemic Lupus Erythematosus (SLE), rheumatoid arthritis, and type I diabetes are the most common autoimmune diseases. An autoimmune disease transfers to a condition wherein the immune system destroys and attacks healthy cells, organs of the body, and tissues. In the longer run, it can further lead to abnormal growth of an organ and changes in organ function.
